Peter graduated with a BS in chemical engineering from Clarkson University in 2022, where he wrote a thesis computationally exploring small peptides that could potentially inhibit SARS-CoV-2 cellular entry via ACE2. In the Sharpe lab, Peter is interested in studying signaling mechanisms which affect T cell differentiation and function in the contexts of cancer and autoimmunity. Outside of lab, Peter enjoys biking, cooking, chess, and trying as many restaurants as possible.